Cargando…

Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome

OBJECTIVE: Women with a prior history of polycystic ovary syndrome (PCOS) have an increased risk of endometrial cancer (EC). AIM: To investigate whether the endometrium of women with PCOS possesses gene expression changes similar to those found in EC. DESIGN AND METHODS: Patients with EC, PCOS and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atiomo, William, Shafiee, Mohamad Nasir, Chapman, Caroline, Metzler, Veronika M., Abouzeid, Jad, Latif, Ayşe, Chadwick, Amy, Kitson, Sarah, Sivalingam, Vanitha N., Stratford, Ian J., Rutland, Catrin S., Persson, Jenny L., Ødum, Niels, Fuentes‐Utrilla, Pablo, Jeyapalan, Jennie N., Heery, David M., Crosbie, Emma J., Mongan, Nigel P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697576/ https://www.ncbi.nlm.nih.gov/pubmed/28748640 http://dx.doi.org/10.1111/cen.13436

Ejemplares similares

Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family
por: Vasiliou, Vasilis, et al.
Publicado: (2006)

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.
por: Ross, D., et al.
Publicado: (1996)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells
por: Siegel, David, et al.
Publicado: (2012)

Aerobic Cytotoxicity of Aromatic N-Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1)
por: Nemeikaitė-Čėnienė, Aušra, et al.
Publicado: (2020)

High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
por: Kitson, Sarah J., et al.
Publicado: (2018)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
por: Stoehr, Christine G., et al.
Publicado: (2012)

NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places
por: Pey, Angel L., et al.
Publicado: (2019)

Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels
por: Nishida-Tamehiro, Kyoko, et al.
Publicado: (2022)

The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties
por: Megarity, Clare F., et al.
Publicado: (2014)

Arylamino-nor-β-lapachone derivative-induced apoptosis in human prostate cancer cells: involvement of NAD(P)H:quinone oxidoreductase (NQO1)
por: Cavalcanti, Bruno C, et al.
Publicado: (2013)

Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H: quinone oxidoreductase 1 (NQO1)
por: Lienhart, Wolf-Dieter, et al.
Publicado: (2017)

FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates β-amyloid aggregation
por: Panja, Sudipta, et al.
Publicado: (2022)

A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells
por: Zhu, Ya, et al.
Publicado: (2019)

Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells
por: Alqahtani, Mohammed A., et al.
Publicado: (2023)

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study
por: Kitson, Sarah J., et al.
Publicado: (2018)

Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone
por: Tsao, Yen-Chi, et al.
Publicado: (2020)

Optimization of Window Study Endpoints in Endometrial Cancer
por: Kitson, Sarah J., et al.
Publicado: (2019)

Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1)
por: Nakamura, Yuko, et al.
Publicado: (2017)

Correction: A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells
por: Zhu, Ya, et al.
Publicado: (2019)

Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment
por: Kim, H-J, et al.
Publicado: (2014)

The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
por: Winger, Jonathan A, et al.
Publicado: (2009)

Evaluation of the risk of lung cancer associated with NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism in male current cigarette smokers from the Eastern India
por: Banerjee, Santanu
Publicado: (2020)

Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
por: Sivalingam, Vanitha N., et al.
Publicado: (2019)

The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer
por: Gorący, Jarosław, et al.
Publicado: (2021)

Riboflavin compounds show NAD(P)H dependent quinone oxidoreductase-like quinone reducing activity
por: Nagase, Midori, et al.
Publicado: (2023)

A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
por: Choudry, G A, et al.
Publicado: (2001)

Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
por: Glorieux, Christophe, et al.
Publicado: (2019)

Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Augmentation of cellular NAD(+) by NQO1 enzymatic action improves age‐related hearing impairment
por: Kim, Hyung‐Jin, et al.
Publicado: (2019)

Identification of NAD(P)H Quinone Oxidoreductase Activity in Azoreductases from P. aeruginosa: Azoreductases and NAD(P)H Quinone Oxidoreductases Belong to the Same FMN-Dependent Superfamily of Enzymes
por: Ryan, Ali, et al.
Publicado: (2014)

NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
por: Lee, Junguee, et al.
Publicado: (2013)

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
por: Traver, R. D., et al.
Publicado: (1997)

Structural Insights into the NAD(P)H:Quinone Oxidoreductase from Phytophthora capsici
por: Yang, Cancan, et al.
Publicado: (2022)

A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy
por: Begleiter, Asher, et al.
Publicado: (2009)

Hybrids of 1,4-Quinone with Quinoline Derivatives: Synthesis, Biological Activity, and Molecular Docking with DT-Diaphorase (NQO1)
por: Kadela-Tomanek, Monika, et al.
Publicado: (2022)

Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary)
por: Osman, Nisreen Abdel Tawab Abdel Gaber, et al.
Publicado: (2015)

Pharmacological activation of NQO1 increases NAD(+) levels and attenuates cisplatin-mediated acute kidney injury in mice
por: Oh, Gi-Su, et al.
Publicado: (2014)

Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2)
por: Zhang, Jing, et al.
Publicado: (2020)

Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations
por: den Braver-Sewradj, Shalenie P., et al.
Publicado: (2017)

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
por: Latif, Ayşe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f3kbr18bo8qmg3p0g1gnvjplce